KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Diversified Healthcare Trust (DHC) EBITDA (2016 - 2025)

Diversified Healthcare Trust (DHC) has disclosed EBITDA for 17 consecutive years, with -$21.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 75.7% year-over-year to -$21.3 million, compared with a TTM value of -$338.9 million through Dec 2025, down 43.8%, and an annual FY2025 reading of -$285.9 million, up 22.79% over the prior year.
  • EBITDA was -$21.3 million for Q4 2025 at Diversified Healthcare Trust, up from -$221.2 million in the prior quarter.
  • Across five years, EBITDA topped out at $430.7 million in Q4 2021 and bottomed at -$221.2 million in Q2 2025.
  • Average EBITDA over 5 years is $15.2 million, with a median of -$21.3 million recorded in 2025.
  • The sharpest move saw EBITDA soared 2552.91% in 2021, then crashed 7292.37% in 2023.
  • Year by year, EBITDA stood at $430.7 million in 2021, then tumbled by 88.42% to $49.9 million in 2022, then tumbled by 162.26% to -$31.0 million in 2023, then crashed by 181.74% to -$87.5 million in 2024, then soared by 75.7% to -$21.3 million in 2025.
  • Business Quant data shows EBITDA for DHC at -$21.3 million in Q4 2025, -$221.2 million in Q2 2025, and -$9.0 million in Q1 2025.